Contact this trialFirst, we need to learn more about you.
Stem Cell Therapy
HB-adMSCs +1 More for Parkinson's Disease
Recruiting0 awardsPhase 2
Sugar Land, Texas
This trial is designed to study whether multiple HB-adMSCs are safe and effective for treating Parkinson's disease. Up to 24 participants will be enrolled, and will be randomly assigned to receive either HB-adMSCs or placebo. The trial will last 32 weeks, with a follow-up period of 20 weeks after the last treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.